These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12101135)

  • 1. Being economical with the truth: how to make your idea appear cost effective.
    Goodacre S; McCabe C
    Emerg Med J; 2002 Jul; 19(4):301-4. PubMed ID: 12101135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bringing health economic modeling to the 21st century.
    Eddy D
    Value Health; 2006; 9(3):168-78. PubMed ID: 16689710
    [No Abstract]   [Full Text] [Related]  

  • 3. The future of health economic modeling: have we gone too far or not far enough?
    Fendrick AM
    Value Health; 2006; 9(3):179-80. PubMed ID: 16689711
    [No Abstract]   [Full Text] [Related]  

  • 4. Equity and the economic evaluation of healthcare.
    Sassi F; Archard L; Le Grand J
    Health Technol Assess; 2001; 5(3):1-138. PubMed ID: 11207451
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative effectiveness research.
    Pentecost MJ
    J Am Coll Radiol; 2009 Aug; 6(8):547-8. PubMed ID: 19643380
    [No Abstract]   [Full Text] [Related]  

  • 6. The imperative to improve.
    Pashos CL
    Value Health; 2009; 12(8):1084-5. PubMed ID: 20667065
    [No Abstract]   [Full Text] [Related]  

  • 7. Reflections: NICE, health economics, and outcomes research.
    Rawlins M
    Value Health; 2012 May; 15(3):568-9. PubMed ID: 22583468
    [No Abstract]   [Full Text] [Related]  

  • 8. Healthcare economics and endophthalmitis.
    Parke DW
    Ophthalmology; 1997 May; 104(5):737-8. PubMed ID: 9160016
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-utility analysis: use QALYs only with great caution.
    McGregor M
    CMAJ; 2003 Feb; 168(4):433-4. PubMed ID: 12591784
    [No Abstract]   [Full Text] [Related]  

  • 10. The Hanover Consensus: helpful for German decision-makers?
    Kolominsky-Rabas PL; Caro JJ
    Value Health; 2008; 11(4):545-6; discussion 547-8. PubMed ID: 18489522
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of cost effectiveness analysis in health care evaluation.
    Atherly A; Culler SD; Becker ER
    Q J Nucl Med; 2000 Jun; 44(2):112-20. PubMed ID: 10967622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economics notes: Converting international cost effectiveness data to UK prices.
    Gosden TB; Torgerson DJ
    BMJ; 2002 Aug; 325(7358):275-6. PubMed ID: 12153929
    [No Abstract]   [Full Text] [Related]  

  • 13. Has health economics lost its way?
    Kernick DP
    BMJ; 1998 Jul; 317(7152):197-9. PubMed ID: 9665908
    [No Abstract]   [Full Text] [Related]  

  • 14. German recommendations on health economic evaluation: third and updated version of the Hanover Consensus.
    Graf von der Schulenburg JM; Greiner W; Jost F; Klusen N; Kubin M; Leidl R; Mittendorf T; Rebscher H; Schoeffski O; Vauth C; Volmer T; Wahler S; Wasem J; Weber C;
    Value Health; 2008; 11(4):539-44. PubMed ID: 18194408
    [No Abstract]   [Full Text] [Related]  

  • 15. Improving the validity of economic evaluations alongside controlled trials.
    Dixon S; Deverill M; Gannon M; Brazier J; Haggard M
    J Health Serv Res Policy; 1999 Jul; 4(3):161-3. PubMed ID: 10538881
    [No Abstract]   [Full Text] [Related]  

  • 16. Understanding cost-effectiveness.
    Zilberberg MD; Shorr AF
    Clin Microbiol Infect; 2010 Dec; 16(12):1707-12. PubMed ID: 20673258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2012 ISMRM Lauterbur Lecture. MRI: from science to society.
    Lee VS
    J Magn Reson Imaging; 2013 Apr; 37(4):753-60. PubMed ID: 23441004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point/counterpoint. Proton therapy is too expensive for the minimal potential improvements in outcome claimed.
    Schulz RJ; Smith AR; Orton CG
    Med Phys; 2007 Apr; 34(4):1135-8. PubMed ID: 17500444
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcomes research priorities in chronic care: a private purchaser perspective.
    Salber PR
    Med Care; 2004 Apr; 42(4 Suppl):III6-10. PubMed ID: 15026665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Philosophical concerns regarding cost-effectiveness analyses.
    Weiner BK
    Med Hypotheses; 2010 Feb; 74(2):383-6. PubMed ID: 19651478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.